Email Alert RSS
Volume 12 Issue 1
Jan.  2021
Turn off MathJax
Article Contents
Abstract
References
WANG Ya-ning, YANG Tian-rui, MA Wen-bin. Postoperative Cognitive Dysfunction in Patients with Brain Tumor[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 99-104. DOI: 10.12290/xhyxzz.20190082
Citation: WANG Ya-ning, YANG Tian-rui, MA Wen-bin. Postoperative Cognitive Dysfunction in Patients with Brain Tumor[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(1): 99-104. DOI: 10.12290/xhyxzz.20190082
shu

Postoperative Cognitive Dysfunction in Patients with Brain Tumor

  • Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

Funds: 

The Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences 2016-I2M-2-001

Tsinghua University-Peking Union Medical College Hospital Initiative Scientific Research Program 2019ZLH101

More Information
  • Corresponding author:

    MA Wen-bin Tel: 86-10-69152530, E-mail: mawb2001@hotmail.com

  • Received Date: May 04, 2019
  • Accepted Date: June 19, 2020
  • Issue Publish Date: January 29, 2021
    Graphical Abstract
    • Abstract
  • With the continuous in-depth research on the treatment of brain tumors and the continuous improvement in patients' requirement of quality of life, as one of common postoperative complications, postoperative cognitive dysfunction (POCD) has gradually attracted more attention. It is currently believed that abnormal expression of cytokines, including inflammatory factors, reactive oxygen species, and high mobility group protein B1, are the molecular mechanism of POCD. Due to the abstractness of cognitive function, in order to better evaluate POCD, a series of scales have been designed clinically. However, how to choose the appropriate approach for different patients is still inconclusive. The treatment of POCD includes drug therapy and non-drug therapy, which is still in the preliminary stage of research and lacks clinical guidelines. This article summarizes the epidemiology, etiology, mechanism, evaluation methods, and treatment options of POCD in patients with brain tumors.
    • FullText(HTML)
    • References (42)
  • [1]
    Jiang T, Mao Y, Ma W, et al. CGCG clinical practice guidelines for the management of adult diffuse gliomas[J]. Cancer Lett, 2016, 375:263-273. DOI: 10.1016/j.canlet.2016.01.024
    [2]
    Cagney DN, Martin AM, Catalano PJ, et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study[J]. Neuro Oncol, 2017, 19:1511-1521. DOI: 10.1093/neuonc/nox077
    [3]
    Kayl AE, Meyers CA. Does brain tumor histology influence cognitive function?[J]. Neuro Oncol, 2003, 5:255-260. DOI: 10.1215/S1152851703000012
    [4]
    Satoer D, Visch-Brink E, Dirven C, Vincent A. Glioma surgery in eloquent areas: can we preserve cognition?[J]. Acta Neurochirurgica, 2015, 158:35-50.
    [5]
    Hendriks EJ, Habets EJJ, Taphoorn MJB, et al. Linking late cognitive outcome with glioma surgery location using resection cavity maps[J]. Hum Brain Mapp, 2018, 39:2064-2074. DOI: 10.1002/hbm.23986
    [6]
    Flechl B, Sax C, Ackerl M, et al. The course of quality of life and neurocognition in newly diagnosed patients with glioblastoma[J]. Radiother Oncol, 2017, 125:228-233. DOI: 10.1016/j.radonc.2017.07.027
    [7]
    Silverstein JH. Cognition, anesthesia, and surgery[J]. Int Anesthesiol Clin, 2014, 52:42-57.
    [8]
    Moller JT, Cluitmans P, Rasmussen LS, et al. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 study[J]. Lancet, 1998, 351:857-861. DOI: 10.1016/S0140-6736(97)07382-0
    [9]
    Steinmetz J, Rasmussen LS. Anesthesia and the risk of dementia in the elderly[J]. Presse Med, 2018, 47:e45-e51. DOI: 10.1016/j.lpm.2018.03.013
    [10]
    Steinmetz J, Christensen KB, Lund T, et al. Long-term Consequences of Postoperative Cognitive Dysfunction[J]. Anesthesiology, 2009, 110:548-555. DOI: 10.1097/ALN.0b013e318195b569
    [11]
    Hudetz JA, Gandhi SD, Iqbal Z, et al. Elevated postopera-tive inflammatory biomarkers are associated with short- and medium-term cognitive dysfunction after coronary artery surgery[J]. J Anesth, 2011, 25:1-9. DOI: 10.1007/s00540-010-1042-y
    [12]
    Skvarc DR, Berk M, Byrne LK, et al. Postoperative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies[J]. Neurosci Biobehav Rev, 2018, 84:116-133. DOI: 10.1016/j.neubiorev.2017.11.011
    [13]
    Peng L, Xu L, Ouyang W. Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis[J]. PLoS One, 2013, 8:e79624. DOI: 10.1371/journal.pone.0079624
    [14]
    Donato R, Heizmann CW. S100B Protein in the Nervous System and Cardiovascular Apparatus in Normal and Pathological Conditions[J]. Cardiovasc Psychiatry Neurol, 2010, 2010:929712.
    [15]
    Adami C, Bianchi R, Pula G, Donato R. S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain[J]. Biochim Biophys Acta, 2004, 1742:169-177. DOI: 10.1016/j.bbamcr.2004.09.008
    [16]
    Harmon D, Eustace N, Ghori K, et al. Plasma concentra-tions of nitric oxide products and cognitive dysfunction following coronary artery bypass surgery[J]. Eur J Anaesthesiol, 2005, 22:269-276. DOI: 10.1017/S0265021505000451
    [17]
    Vacas S, Degos V, Tracey KJ, et al. High-mobility group box 1 protein initiates postoperative cognitive decline by engaging bone marrow-derived macrophages[J]. Anesthesiology, 2014, 120:1160-1167. DOI: 10.1097/ALN.0000000000000045
    [18]
    Li YC, Xi CH, An YF, et al. Perioperative inflammatory response and protein S-100beta concentrations-relationship with post-operative cognitive dysfunction in elderly patients[J]. Acta Anaesthesiol Scand, 2012, 56:595-600. DOI: 10.1111/j.1399-6576.2011.02616.x
    [19]
    Hansson L, Lithell H, Skoog I, et al. Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics[J]. Blood Press, 2000, 9:146-151. DOI: 10.1080/080370500453483999
    [20]
    Skoog I, Lithell H, Hansson L, et al. Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)[J]. Am J Hypertens, 2005, 18:1052-1059. DOI: 10.1016/j.amjhyper.2005.02.013
    [21]
    Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment[J]. J Am Geriatr Soc, 2005, 53:695-699. DOI: 10.1111/j.1532-5415.2005.53221.x
    [22]
    Hoops S, Nazem S, Siderowf AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease[J]. Neurology, 2009, 73:1738-1745. DOI: 10.1212/WNL.0b013e3181c34b47
    [23]
    Brown PD, Buckner JC, O'Fallon JR, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination[J]. J Clin Oncol, 2003, 21:2519-2524. DOI: 10.1200/JCO.2003.04.172
    [24]
    Rambeau A, Beauplet B, Laviec H, et al. Prospective comparison of the Montreal Cognitive Assessment (MoCA) and the Mini Mental State Examination (MMSE) in geriatric oncology[J]. J Geriatr Oncol, 2019, 10:235-240. DOI: 10.1016/j.jgo.2018.08.003
    [25]
    马文斌, 王裕, 王樑, 等.中国老年胶质瘤患者术前评估专家共识(2019)[J].协和医学杂志, 2019, 10:326-335. DOI: 10.3969/j.issn.1674-9081.2019.04.004

    Ma WB, Wang Y, Wang L, et al. Expert Consensus on the Preoperative Geriatric Assessments of Elderly Patients with Glioma(2019)[J]. Xie He Yi Xue Za Zhi, 2019, 10:326-335. DOI: 10.3969/j.issn.1674-9081.2019.04.004
    [26]
    Bommakanti K, Somayajula S, Suvarna A, et al. Pre-operative and post-operative cognitive deficits in patients with supratentorial meningiomas[J]. Clin Neurol Neurosurg, 2016, 143:150-158. DOI: 10.1016/j.clineuro.2016.02.033
    [27]
    Hoffermann M, Bruckmann L, Mahdy Ali K, et al. Pre-and postoperative neurocognitive deficits in brain tumor patients assessed by a computer based screening test[J]. J Clin Neurosci, 2017, 36:31-36. DOI: 10.1016/j.jocn.2016.10.030
    [28]
    Gehring K, Aaronson NK, Taphoorn MJ, et al. Interventions for cognitive deficits in patients with a brain tumor: an update[J]. Expert Rev Anticancer Ther, 2010, 10:1779-1795. DOI: 10.1586/era.10.163
    [29]
    Hassler MR, Elandt K, Preusser M, et al. Neurocognitive training in patients with high-grade glioma: a pilot study[J]. J Neurooncol, 2010, 97:109-115. DOI: 10.1007/s11060-009-0006-2
    [30]
    Gehring K, Sitskoorn MM, Gundy CM, et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial[J]. J Clin Oncol, 2009, 27:3712-3722. DOI: 10.1200/JCO.2008.20.5765
    [31]
    Butler JM Jr, Case LD, Atkins J, et al. A phase Ⅲ, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy[J]. Int J Radiat Oncol Biol Phys, 2007, 69:1496-1501. DOI: 10.1016/j.ijrobp.2007.05.076
    [32]
    Page BR, Shaw EG, Lu L, et al. Phase Ⅱ double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue[J]. Neurooncology, 2015, 17:1393-1401.
    [33]
    Birks JS, Harvey RJ. Donepezil for dementia due to Alzheimer's disease[J]. Cochrane Database Syst Rev, 2018, 6:Cd001190.
    [34]
    Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease[J]. New Engl J Med, 2012, 366:893-903. DOI: 10.1056/NEJMoa1106668
    [35]
    Grön G, Kirstein M, Thielscher A, et al. Cholinergic enhancement of episodic memory in healthy young adults[J]. Psychopharmacology, 2005, 182:170-179. DOI: 10.1007/s00213-005-0043-2
    [36]
    Ceravolo R, Volterrani D, Tognoni G, et al. Cerebral perfusional effects of cholinesterase inhibitors in Alzheimer disease[J]. Clin Neuropharmacol, 2004, 27:166-170. DOI: 10.1097/01.wnf.0000138636.42121.45
    [37]
    Shaw EG, Rosdhal R, D'Agostino RB Jr, et al. Phase Ⅱ study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life[J]. J Clin Oncol, 2006, 24:1415-1420. DOI: 10.1200/JCO.2005.03.3001
    [38]
    Rapp SR, Case LD, Peiffer A, et al. Donepezil for Irradiated Brain Tumor Survivors: A Phase Ⅲ Randomized Placebo-Controlled Clinical Trial[J]. J Clin Oncol, 2015, 33:1653-1659. DOI: 10.1200/JCO.2014.58.4508
    [39]
    Danysz W, Parsons CG, Karcz-Kubicha M, et al. GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality[J]. Amino Acids, 1998, 14:235-239. DOI: 10.1007/BF01345268
    [40]
    Chen HS, Pellegrini JW, Aggarwal SK, et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity[J]. J Neurosci, 1992, 12:4427-4436. DOI: 10.1523/JNEUROSCI.12-11-04427.1992
    [41]
    Chen HS, Lipton SA. Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism[J]. J physiol, 1997, 499:27-46. DOI: 10.1113/jphysiol.1997.sp021909
    [42]
    Brown PD, Pugh S, Laack NN, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial[J]. Neurooncology, 2013, 15:1429-1437.
    • Related Articles

  • Cited by

    Periodical cited type(6)

    1. 周卫萍，张英，李艳贞，李琛琛. 聚焦解决模式护理对颅脑肿瘤术后认知及情绪的影响. 国际精神病学杂志. 2024(01): 322-324 .
    2. 杨琴，张明月，严静，孙启媛，张锐，付晓凡，唐智勇. 颅内肿瘤病人术后住院期间真实体验的质性研究. 全科护理. 2024(07): 1376-1379 .
    3. 陆朋玮，蔡卫新，霍玉萌，薛宁宁，苗亚杰. 基于临床路径的智慧化脑肿瘤健康教育路径构建与临床应用. 重庆医学. 2024(07): 1111-1114 .
    4. 毕新颖，李敏. 老年胃癌根治术病人术后认知功能障碍形成的独立危险因素及护理对策研究. 全科护理. 2022(10): 1410-1413 .
    5. 易垒，张宗平，谭鑫，冯海滨，叶锋，吴小花，沈晓丹，陈冬花，黎晓燕，黄敏. 中颅窝脑膜瘤瘤周引流静脉保护对术后记忆力及执行力的影响. 广东医科大学学报. 2022(05): 519-522 .
    6. 边志民. 老年肿瘤患者合并术后认知功能障碍的影响因素及诊断防治策略. 中国现代医学杂志. 2021(13): 1-4 .

    Other cited types(3)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (868) PDF downloads (34) Cited by(9)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close